Expert opinion paper on the treatment of hemophilia B with albutrepenonacog alfa

Autor: Roman, MTA, Benitez, O, Canaro, MI, Fernandez, MFL, Jaime, FLJ, Arranz, JM, Nunez, R, Lopez, MR, Aisa, CS, Jimenez-Yuste, V

Publikováno v: EXPERT OPINION ON BIOLOGICAL THERAPY
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname

Introduction: Current guidelines recommend prophylactic treatment of hemophilia B with the missing coagulation factor IX, either with standard half-life or extended half-life products. Extended half-life products have half-lives three to six times lo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::43e905fc5c8b02cf0f3041385ded0976
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=4533